Cytokine-induced inflammation in the central nervous system revisited

Neurochemical Research

Volumn 23, Issue 3, 1998, Pages 349-359

  Martiney, James A ^a   Cuff, Carolyn ^b   Litwak, Mona ^c   Berman, Joan ^c   Brosnan, Celia F ^c  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adhesion molecules; Chemokines; CNS inflammation; Cytokines; Neuroimmunology; Review

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT INTERLEUKIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; BLOOD BRAIN BARRIER; ENCEPHALITIS; ENDOTHELIUM CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; CYTOKINES; HUMANS; INFLAMMATION;

EID: 0031909986     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022457500700     Document Type: Review

References (65)

1. Ward, P. A. 1991. Mechanisms of endothelial cell injury. J. Lab. Clin. Med. 118:421-426
2. Birkedal-Hansen, H. 1993. Role of cytokines and inflammatory mediators in tissue destruction. J. Period. Res. 28:500-10.
3. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Ann. Rev. Immunol. 10:411-51.
4. Dinarello, C. A. 1994. The interleukin-1 family: 10 years of discovery. FASEB J. 8:1314-1325.
5. Carlos, T. M., and Harlan, J. M. 1994. Leukocyte-endothelial adhesion molecules. Blood 84:2068-101.
6. Schall, T. J., and Bacon, K. B. 1994. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6:865-73.
7. Musso, T., Espinoza-Delgado, I., Pulkki, K., Gusella, G. L., Longo, D. L., and Varesio, L., 1990. Transforming growth factor beta downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood 76:2466-2469.
8. Zentella, A., Manogue, K., and Cerami, A. 1991. The role of cachectin/TNF and other cytokines in sepsis. Prog. Clin. Biol. Res. 367:9-24.
9. Tracey, K. J., and Cerami, A. 1994. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Ann. Rev. Med. 45:491.
10. Quaglierello, V. J., Wispelwey, B. Jr., W. J. L., and Scheid, W. M. 1991. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J. Clin. Invest. 87:1360-1366.
11. Rosenbaum, J. T., Samples, J. R., Hefeneider, S. H., and Howes, E. L. 1987. Ocular inflammatory effects of intravitreal interleukin 1. Arch. Opthalmol. 105:1117-1120.
12. Martiney, J. A., Litwak, M., Berman, J. W., Arezzo, J. C., and C. F. Brosnan. 1990. Pathophysiologic effect of interleukin-1β in the rabbit retina. Am. J. Pathol. 137:1411-1423.
13. Simmons, R. D., and Willenborg, D. O. 1990. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100:37-42.
14. Perry, V. H., Bell., M. D., Brown, H. C., and M. K. Matyszak. 1995. Inflammation in the nervous system [Review] Curr. Op. Neurobiol. 5:636-41.
15. Pflster, H.-W., Frei, K., Ottnad, B., Koedel, U., Tomasz A., and A. Fontana. 1992 Transforming growth factor β inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor-α-independent early phase of experimental pneumococcal meningitis. J. Exp. Med. 176:265-8.
16. Brosnan, C. F., Claudio, L., and J. A. Martiney. 1992. The blood-brain barrier during immune responses. Semin. Neurosci. 4:193-200.
17. Perry, V. H., Anderson, P.-B., and Gordon, S. 1993. Macrophages and inflammation the central nervous system. TINS 16:268-73.
18. Claudio, L, Martiney, J. A., and Brosnan, C. F. 1994. Ultrastructural studies on the blood-retina barrier after exposure to interleukin-1β or tumor necrosis factor-α. Lab. Invest. 70:850-61.
19. Bevilacqua, M. P. 1993. Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol. 11:767-804.
20. Muller, W. A., Weigl, S. A., Deng, X., and Phillips, D. M. 1993. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178:449-60.
21. Albelda, S. M., and Buck, C. A., 1990. Integrins and other cell adhesion molecules. FASEB J. 4:2868-2878.
22. Taub, D. D., and Oppenheim, J. J. 1994. Chemokines, inflammation and the immune system. Ther. Immunol. 1:229-246.
23. Glabinski, A. R., Tani, M., Aras, S., Stoler, M. H., Tuohy, V. K., and Ransohoff, R. M. 1995. Regulation and function of central nervous system chemokines. [Review] Int. J. Dev, Sci. 13:153-65.
24. Mackay, C. R. 1996. Chemokine receptors and T cell chemotaxis. J. Exp. Med. 184:799-802.
25. Hulkower, K., Brosnan, C. F., Aquino, D. A., Cammer, W., Kulshrestha, S., Guida, M. P., Rapoport, D. A., and Berman, J. W. 1993. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J. Immunol. 150:2525-33.
26. Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., Estes, M. L., Thomas, D. M., and V. K. Tuohy. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:592-600.
27. Berman, J. W., Guida, M. P., Warren, J., Amat, J., and Brosnan, C. F., (1996) Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 156:3017-23.
28. Karpus, W. J., Lukacs, N. W., McRae, B. L., Stricter, R. M., Kunkel, S. L., and Miller, S. D. 1995. An important role for the chemokines macrophage inflammatory protein-1α in the patho-genesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:5003-10.
29. Baggiolini, M., Dewald, B., and Moser, B. 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:97-179.
30. Hickey, W. F., and Kimura, H. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290-292.
31. Cuff, C., Berman, J. W., and Brosnan, C. F. 1996. The ordered array of perivascular macrophages is disrupted by IL-1-induced inflammation in the rabbit retina. Glia 17:307-16.
32. Roake, J. D., Rao, A. S., Morris, P. J., Larsen, C. P., Hankins, D. F., and Austyn, J. M. 1995. Dendritic ceil loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1 J. Exp. Med. 181:2237-2247
33. Miller, S. D., and Karpus, W. J. 1994. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today 15:356-61.
34. Wahl, S. M. 1994. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180:1587-90.
35. Kulkarni, A. B., Ward, J. M., Yaswen, L., Mackall, C. L., Bauer, S. R., Huh, C. G., Gress, R. E., and Karlsson, S. 1995. Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. Am. J. Pathol. 146:264-75.
36. Christ, M., McCartney-Francis, N. L., Kulkami, A. B., Ward, J. B., Mizel, D. E., Mackall, C. L., Gress, R. E., Himes, K. L., Tian, H., and Karlsson, S. et al. 1994. Immune dysregulation in TGF-beta 1-deficient mice. J. Immunol. 153:1936-46.
37. Boivin, G. P., O'Toole, B. A., Orsmby, I. E., Diebold, R. J., Eis, M. J., Doetschman, T., and Kier, A. B. 1995. Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. Am. J. Pathol. 146:276-88.
38. Cai, J.-P., Falanga, V., and Chin, Y.-H. 1991. Transforming growth factor-β regulates the adhesive interactions between mononuclear cells and microvascular endothelium. J. Invest. Dermatol. 97:169-174.
39. Gamble, J. R., and Vadas, M. A. 1988. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β. Science 242:97-99.
40. Gamble, J. R., and Vadas, M. A. 1991. Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-β. J. Immunol. 146:1149-1154.
41. Wilbanks, G. A., Mammoleni, M., and Streilein, J. W. 1992. Studies on the induction of anterior chamber-associated immune deviation (ACAID) III. Induction of ACAID depends upon intraocular transforming growth factor-β. Eur. J. Immunol. 22:165-173.
42. Streilein, J. W. 1987. Immune regulation and the eye: a dangerous compromise. FASEB Journal 1:199-208.
43. Cannella, B., and Raine, C. S. 1995. The adhesion molecule profile and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:424-35.
44. Hafler, D. A., and Weiner, H. L. 1995. Immunological mechanisms and therapy in multiple sclerosis (Review) Immunol. Rev. 144:75-107.
45. Issazadeh S., Mustafa, M., Ljungdahl, A., Hojeberg, B., Dagerlind, A., Elde, R., and Olsson, T. 1995. Interferon gamma, interleukin 4 and transforming growth factor-beta in experimental autoimmune encephalitis in Lewis rats: Dynamics of cellular mRNA express in the CNS and lymphoid cells. J. Neurosci. Res. 40:579-90.
46. Brosnan, C. F., Racke, M. K., and Selmaj, K. 1997. An investigational approach to disease therapy in multiple sclerosis. In, Multiple sclerosis: Clinical and pathogenetic basis. Eds. C. S. Raine, H. F. MacFarland, & W. W. Tourtellotte. Chapman & Hall, London, p 325-340.
47. Cuff, C. A., Martiney, J. A., Berman, J. W., and Brosnan, C. F. 1996. Differential effects of transforming growth factor-β1 on IL-1-induced cellular inflammation and vascular permeability in the rabbit retina. J. Neuroimmunol., 70:21.
48. Wyss-Coray, T., Feng, L., Masliah, E. Ruppe, M. D., Lee, H. S., Toggas, S. M., Rockenstein, E. M., and Mucke L. 1995. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice over expressing transforming growth factor β1. Am. J. Path. 147:53-57.
49. Subramaniam, M., Saffaripour, S., Watson, S. R., Mayadas, T. N., Hynes, R. O., and Wagner, D. D. 1995. Reduced recruitment of inflammatory cells in a contact hypersensitivity response in P-selectin-deficient mice. J. Exp. Med. 181:2277-2282.
50. Beck, J., Rondot, P., Jullien, P., Wietzerbin, J., and Lawrence, D. A. 1991. TGFβ-like activity produced during regression of exacerbations of multiple sclerosis. Acta Neurol. Scand. 84:452-455.
51. Stone, L. A., Frank, J. A., Albert, P. S., Bash C., Smith, M. E., Maloni, H., and McFarland, H. F. 1995. The effect of interferon-β on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann. Neurol. 37:611-619.
52. Huynh, H. K., Oger, J., and Dorovini-Zis, K. 1995. Interferon-β downregulates interferon-γ-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells. J. Neuroimmunol. 60:63-73.
53. Claudio, L., Raine, C. S., and Brosnan, C. F. 1995. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropath. 90:228-238.
54. Kwon, E. E., and J. W. Prineas. 1994. Blood-brain barrier abnormalities in long-standing multiple sclerosis lesions. An immunohistochemical study. J. Neuropath. Exptl. Neurol. 53:625-36.
55. Martiney, J. A., Herman, J. W., and C. F. Brosnan. 1992. Chronic inflammatory effects of interleukin-1b on the blood-retina barrier. J. Neuroimmunol. 41:167-176.
56. Rosenberg, G. A., Dencoff, J. E., Correa, N. Jr., Reiners, M., and C. C., Ford. 1996. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 46:1626-32.
57. Dorovini-Zis, K., Bowman, P. D., and R. Prameya. 1992. J. Neuropath. Exp. Neurol. 51:194-205.
58. Cross, A. 1992. Immune cell traffic control and the central nervous system. Semin Neurosci. 4:213-219.
59. Claudio, L., Kress, Y., Factor, J., and C. F. Brosnan. 1990. Mechanisms of edema formation in experimental autoimmune encephalomyelitis; the contribution of inflammatory cells. Amer. J. Path. 137:1033-1045.
60. Burger, D., and J-M., Dayer. 1995. Inhibitory cytokines and cytokine inhibitors. Neurology 45:S39-S43.
61. Selmaj, K., and C. S. Raine. 1995. Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble rumor necrosis factor antibodies. Neurology 45:844-9.
62. Fabry, Z., Fitzsimmons, K. M., Herlein, J.A., Moninger, T. O., Dobbs, M. B., and M. N. Hart. 1993. Production of cytokines interleukin-1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J. Neuroimmunol. 47:23-34.
63. Jemison, L. M., Williams, S. K., Lublin, F. D., Knobler, R. L., and R. Korngold. 1993. Interferon-γ-inducible endothelial cell class II MHC expression correlates with strain and site-specific susceptibility to experimental allergic encephalomyelitis. J. Neuroimmunol. 47:15-22.
64. Guida, J. D., Fejer, G., Pirofski, L-A., Brosnan, C. F., and M. S. Horwitz. 1995. Mouse adenovirus type I causes a fatal hemorrhagic encephalomyelitis in adult C57B1/6 but not BALB/c mice. J. Virol. 69:7674-81.
65. Godfraind, C., Langreth, S. G., Cardellichio, C. B., Knobler, R., Coutelier, J-P., Dubois-Dalcq, M., and K. Holmes. 1995. Tissue and cellular distribution of an adhesion molecule in the carcinoembryonic antigen family that serves as a receptor for mouse hepatitis virus. Lab. Invest. 73:615-27.